ADAP   $0.66  3.13% Market Closed After Close 0.66 0.0

Adaptimmune Therapeutics PLC

EMA (20): 2024-11-12 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2024-09-05 the price crossed down the moving average line and demonstrates a downside trend.

EMA (100): 2024-09-05 the price crossed down the moving average line and demonstrates a strong downside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: exit from the oversold zone.

Trend Type turning down
Power medium strength
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -20.04%
EMA (20) date of signal Nov. 12, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -43.16%
EMA (50) date of signal Sept. 5, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -43.16%
EMA (100) date of signal Sept. 5, 2024, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -4.23%
RSI (14) date of signal Nov. 20, 2024, 3 a.m.
MACD Signals bearish recovery
MACD Yield 0.0
MACD date of signal Nov. 21, 2024, 3 a.m.
Stochastic Signals bullish reversal
Stochastic Yield -4.23%
Stochastic date of signal Nov. 20, 2024, 3 a.m.
Updated Nov. 22, 2024, 11 p.m.